Found 5 matching trials
Absolute Bioavailability of Reslizumab in Healthy Subjects
PHASE1The primary objective of this study is to assess the absolute bioavailabili...
Location
Teva Investigational Site 10567
Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists
PHASE1This study is designed to assess pharmacokinetics and pharmacodynamics of m...
Location
Spaulding Clinical Research
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
PHASE2Background:
Hypereosinophilic syndrome (HES) is a blood disorder that caus...
Location
National Institutes of Health Clinical Center
A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
PHASE3This is a multicenter, open-label (OL) extension study to obtain additional...
Location
Teva Investigational Site 14647
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
PHASE3The primary objective of the study is to determine the ability of reslizuma...
Location
Teva Investigational Site 13357